GW-50151 by Genetix Pharma

(50 Tablets, 10mg Each)

GW-50151, also known as Cardarine, is a cutting-edge performance enhancer crafted by Genetix Pharma for Canadian men aged 18 to 55. Designed to elevate endurance, enhance fat loss, and boost overall physical performance, GW-50151 is the go-to supplement for athletes and fitness enthusiasts striving to achieve their peak. Each bottle contains 50 tablets, delivering a potent 10mg dose per tablet to fuel your fitness journey effectively.

Why Choose Genetix Pharma’s GW-50151?

Genetix Pharma is trusted for its commitment to precision, purity, and performance. Each batch of GW-50151 undergoes rigorous testing to ensure consistency and effectiveness. With every tablet, you can trust that you’re receiving a product designed to meet the highest standards of quality.

Whether you’re preparing for an event, pushing through a challenging training phase, or striving to improve your day-to-day stamina, GW-50151 provides a safe and effective way to reach your fitness potential.

Product Details

• Product Name: GW-50151
• Tablets per Bottle: 50
• Dosage per Tablet: 10mg

Follow the recommended guidelines for optimal results. Incorporate GW-50151 into your daily routine and experience its transformative effects on your endurance, fat loss, and overall performance. Explore GW-50151 by Genetix Pharma USA

Explore GW-50151 by Genetix Pharma USA

Medical Uses

GW 501516, also known as GW1516 or Cardarine, is an experimental compound that acts as a PPAR delta receptor agonist. It is not an FDA approved medicine and does not have an FDA approved medical indication.

GW 501516 was investigated in research involving metabolic and cardiovascular conditions, but research findings do not establish an approved treatment. The FDA substance database identifies GW 501516 and its alternative names but specifically notes that inclusion in the database does not imply regulatory approval.

There are therefore no established FDA approved medical uses for a product marketed as GW 501516 Genetix Pharma.

U.S. Safety Information

GW 501516 has not received FDA approval for human medical use. The FDA has identified products containing GW 501516 that were marketed for human use as unapproved new drugs.

A major concern with GW 501516 is its experimental safety profile. Development of the compound was discontinued after concerning findings in long term animal studies, including findings involving cancer. These findings are an important reason the compound should not be regarded as an established human medicine.

Because GW 501516 products marketed outside the FDA approval system have not undergone the normal product specific review, their identity, purity, manufacturing quality, and labeling cannot be assumed to meet pharmaceutical standards. The FDA explains that unapproved drugs have not been evaluated for safety, effectiveness, or consistent quality. Explore GW-50151 by Genetix Pharma USA

GW 501516 is also prohibited under the World Anti Doping Agency prohibited list. WADA classifies it as a PPAR delta agonist within the metabolic modulators category.

FAQs

What is GW 501516

GW 501516 is an experimental PPAR delta receptor agonist. It is also known as GW1516 and Cardarine.

Is GW 501516 FDA approved

No. GW 501516 is not an FDA approved human medicine.

Does GW 501516 have approved medical uses

No. There are currently no FDA approved medical indications for GW 501516.

Is GW 501516 a steroid

No. GW 501516 is not an anabolic steroid or SARM. It is a PPAR delta receptor agonist.

Is Genetix Pharma GW 501516 FDA approved

The Genetix Pharma name does not establish FDA approval. FDA approval applies to a specific drug product that has undergone regulatory review for safety, effectiveness, quality, and manufacturing.

Is GW 501516 legal as a dietary supplement in the United States

It should not be treated as an FDA approved dietary supplement. The FDA has taken enforcement action against companies marketing GW 501516 products as unapproved drugs.

Is GW 501516 prohibited in sports

Yes. WADA lists GW 501516 and GW1516 as prohibited substances.

Why is GW 501516 considered experimental

It was investigated as a potential treatment affecting metabolic pathways, but it did not progress to an approved human medicine. Important safety concerns emerged during development, preventing it from being considered an established therapeutic option.

Conclusion

GW 501516, also known as GW1516 or Cardarine, is an experimental PPAR delta agonist and not an FDA approved human medicine.

It has no FDA approved medical indication, and commercial products marketed under names such as Genetix Pharma should not be assumed to have been evaluated by the FDA for safety, effectiveness, purity, or manufacturing quality.

Its experimental status and significant safety concerns mean it should not be presented as an established treatment or dietary supplement.Explore GW-50151 by Genetix Pharma USA